Company
Cognito TX
We are leading a novel category of non-invasive neuroprotective therapy in Alzheimer’s disease with Spectris
Also known as Cognito Therapeutics
- Business model
- B2B
- Customers
- patients living with neurodegenerative diseases
- Legal name
- Cognito Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Cognito is developing novel and innovative therapeutics designed to potentially improve the lives of patients living with neurodegenerative diseases.
Funding snapshot
- Total raised
- $119MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $10.2M2024-06-18
Funding rounds
- Round, 2024
- $10.2M2024-06-18, SEC form D sold, 3 investors
- Round, 2022
- $109M2022-06-16, SEC form D sold, 13 investors
Products
- Web
- Spectris
Loading relationship preview